You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

carboplatin

Showing 1 - 25 of 1,574
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Netherlands, Spain (Debio 0123, Carboplatin)

Recruiting
  • Advanced Solid Tumors
  • Debio 0123
  • Carboplatin
  • Groningen, Netherlands
  • +3 more
Aug 19, 2022

Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Sep 29, 2022

NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • (no location specified)
Jan 18, 2023

Breast Tumor Trial in Shanghai (Decitabine, Carboplatin)

Terminated
  • Breast Neoplasm
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

NSCLC Trial in Seoul (Atezolizumab(Tecentriq), Pemetrexed, Bevacizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Seoul, Gangnamgu, Korea, Republic of
    Samsung Medical Center
Dec 27, 2021

Adenocarcinoma of Lung, NSCLC Trial in Rolling Meadows (LP-300, Pemetrexed, Carboplatin)

Not yet recruiting
  • Adenocarcinoma of Lung
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 8, 2022

Gynecologic Malignancies Trial in Cleveland (Paclitaxel, Carboplatin)

Terminated
Has Results
  • Gynecologic Malignancies
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jun 29, 2022

Breast Cancer Trial in New York (Carboplatin, Everolimus)

Recruiting
  • Breast Cancer
  • New York, New York
  • +2 more
Oct 22, 2021

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • Carboplatin
  • (no location specified)
Jun 22, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Seattle

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Carboplatin
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 10, 2022

Breast Cancer Trial in Cincinnati, Houston (Docetaxel, Carboplatin)

Active, not recruiting
Has Results
  • Breast Cancer
  • Cincinnati, Ohio
  • +2 more
Apr 6, 2022

Triple Negative Breast Cancer Trial in Chicago (Carboplatin, Paclitaxel, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Carboplatin
  • +3 more
  • Chicago, Illinois
    University of Illinois
Jan 28, 2022

High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)

Not yet recruiting
  • High Grade Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • Carboplatin
  • (no location specified)
Jul 11, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Carboplatin
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
Jun 28, 2022

NSCLC Metastatic Trial in Salt Lake City (Durvalumab, Pemetrexed, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Mar 1, 2022

Metastatic Medulloblastoma, High Risk Supratentorial PNET, Metastatic PNET Trial in Aurora (Carboplatin, Vincristine, 24 Gy)

Completed
Has Results
  • Metastatic Medulloblastoma
  • +2 more
  • Carboplatin
  • +2 more
  • Aurora, Colorado
    Children's Hospital Colorado
Dec 13, 2021

Triple-negative Breast Cancer Trial in Shanghai (chidamide, camrelizumab, carboplatin)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2022

Lung Adenocarcinoma, Cryotherapy Effect Trial in Bordeaux (Cryoablation, Pembrolizumab, Pemetrexed)

Recruiting
  • Lung Adenocarcinoma
  • Cryotherapy Effect
  • Cryoablation
  • +3 more
  • Bordeaux, Gironde, France
    Institut Bergonié
Oct 29, 2021

Advanced Solid Tumors Trial (ABBV-706, Cisplatin, Budigalimab)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Oct 28, 2022

Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

Withdrawn
  • Salivary Gland Carcinoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 5, 2022

Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)

Recruiting
  • Recurrent Non-small Cell Lung Cancer
  • Changchun, Jilin, China
  • +2 more
May 3, 2022

NSCLC Trial in Philadelphia (Carboplatin, Paclitaxel, Ramucirumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Carboplatin
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 14, 2022

Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)

Not yet recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Dec 2, 2022

NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Arkhangel'sk, Russian Federation
  • +10 more
Dec 8, 2022

Fallopian Tube Cancer, Peritoneum Cancer, Epithelial Ovarian Cancer Trial in Miami (Pembrolizumab, Paclitaxel, Carboplatin)

Recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Miami, Florida
    University of Miami
Dec 24, 2021